img

Global Anti-D Immunoglobulin Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-D Immunoglobulin Market Insights, Forecast to 2034

To prevent sensitisation in cases where the mother’s immune system may attack the baby’s red blood cells during pregnancy, thus avoiding harm to the foetus.
Global Anti-D Immunoglobulin market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Anti-D Immunoglobulin industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Anti-D Immunoglobulin market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Anti-D Immunoglobulin market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Octapharma
Kedrion Biopharma
Grifols
Saol Therapeutics
Bayer
Bio Products Laboratory
Segment by Type
Vial
Prefilled Syringes

Segment by Application


Hospital
Clinic

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Anti-D Immunoglobulin plant distribution, commercial date of Anti-D Immunoglobulin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Anti-D Immunoglobulin introduction, etc. Anti-D Immunoglobulin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Anti-D Immunoglobulin
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Anti-D Immunoglobulin Product Introduction
1.2 Market by Type
1.2.1 Global Anti-D Immunoglobulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Vial
1.2.3 Prefilled Syringes
1.3 Market by Application
1.3.1 Global Anti-D Immunoglobulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anti-D Immunoglobulin Sales Estimates and Forecasts 2018-2029
2.2 Global Anti-D Immunoglobulin Revenue by Region
2.2.1 Global Anti-D Immunoglobulin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Anti-D Immunoglobulin Revenue by Region (2018-2024)
2.2.3 Global Anti-D Immunoglobulin Revenue by Region (2024-2029)
2.2.4 Global Anti-D Immunoglobulin Revenue Market Share by Region (2018-2029)
2.3 Global Anti-D Immunoglobulin Sales Estimates and Forecasts 2018-2029
2.4 Global Anti-D Immunoglobulin Sales by Region
2.4.1 Global Anti-D Immunoglobulin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Anti-D Immunoglobulin Sales by Region (2018-2024)
2.4.3 Global Anti-D Immunoglobulin Sales by Region (2024-2029)
2.4.4 Global Anti-D Immunoglobulin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Anti-D Immunoglobulin Sales by Manufacturers
3.1.1 Global Anti-D Immunoglobulin Sales by Manufacturers (2018-2024)
3.1.2 Global Anti-D Immunoglobulin Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-D Immunoglobulin in 2022
3.2 Global Anti-D Immunoglobulin Revenue by Manufacturers
3.2.1 Global Anti-D Immunoglobulin Revenue by Manufacturers (2018-2024)
3.2.2 Global Anti-D Immunoglobulin Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Anti-D Immunoglobulin Revenue in 2022
3.3 Global Key Players of Anti-D Immunoglobulin, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Anti-D Immunoglobulin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Anti-D Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Anti-D Immunoglobulin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Anti-D Immunoglobulin, Product Offered and Application
3.8 Global Key Manufacturers of Anti-D Immunoglobulin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-D Immunoglobulin Sales by Type
4.1.1 Global Anti-D Immunoglobulin Historical Sales by Type (2018-2024)
4.1.2 Global Anti-D Immunoglobulin Forecasted Sales by Type (2024-2029)
4.1.3 Global Anti-D Immunoglobulin Sales Market Share by Type (2018-2029)
4.2 Global Anti-D Immunoglobulin Revenue by Type
4.2.1 Global Anti-D Immunoglobulin Historical Revenue by Type (2018-2024)
4.2.2 Global Anti-D Immunoglobulin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Anti-D Immunoglobulin Revenue Market Share by Type (2018-2029)
4.3 Global Anti-D Immunoglobulin Price by Type
4.3.1 Global Anti-D Immunoglobulin Price by Type (2018-2024)
4.3.2 Global Anti-D Immunoglobulin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Anti-D Immunoglobulin Sales by Application
5.1.1 Global Anti-D Immunoglobulin Historical Sales by Application (2018-2024)
5.1.2 Global Anti-D Immunoglobulin Forecasted Sales by Application (2024-2029)
5.1.3 Global Anti-D Immunoglobulin Sales Market Share by Application (2018-2029)
5.2 Global Anti-D Immunoglobulin Revenue by Application
5.2.1 Global Anti-D Immunoglobulin Historical Revenue by Application (2018-2024)
5.2.2 Global Anti-D Immunoglobulin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Anti-D Immunoglobulin Revenue Market Share by Application (2018-2029)
5.3 Global Anti-D Immunoglobulin Price by Application
5.3.1 Global Anti-D Immunoglobulin Price by Application (2018-2024)
5.3.2 Global Anti-D Immunoglobulin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Anti-D Immunoglobulin Market Size by Type
6.1.1 US & Canada Anti-D Immunoglobulin Sales by Type (2018-2029)
6.1.2 US & Canada Anti-D Immunoglobulin Revenue by Type (2018-2029)
6.2 US & Canada Anti-D Immunoglobulin Market Size by Application
6.2.1 US & Canada Anti-D Immunoglobulin Sales by Application (2018-2029)
6.2.2 US & Canada Anti-D Immunoglobulin Revenue by Application (2018-2029)
6.3 US & Canada Anti-D Immunoglobulin Market Size by Country
6.3.1 US & Canada Anti-D Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Anti-D Immunoglobulin Sales by Country (2018-2029)
6.3.3 US & Canada Anti-D Immunoglobulin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Anti-D Immunoglobulin Market Size by Type
7.1.1 Europe Anti-D Immunoglobulin Sales by Type (2018-2029)
7.1.2 Europe Anti-D Immunoglobulin Revenue by Type (2018-2029)
7.2 Europe Anti-D Immunoglobulin Market Size by Application
7.2.1 Europe Anti-D Immunoglobulin Sales by Application (2018-2029)
7.2.2 Europe Anti-D Immunoglobulin Revenue by Application (2018-2029)
7.3 Europe Anti-D Immunoglobulin Market Size by Country
7.3.1 Europe Anti-D Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Anti-D Immunoglobulin Sales by Country (2018-2029)
7.3.3 Europe Anti-D Immunoglobulin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Anti-D Immunoglobulin Market Size
8.1.1 China Anti-D Immunoglobulin Sales (2018-2029)
8.1.2 China Anti-D Immunoglobulin Revenue (2018-2029)
8.2 China Anti-D Immunoglobulin Market Size by Application
8.2.1 China Anti-D Immunoglobulin Sales by Application (2018-2029)
8.2.2 China Anti-D Immunoglobulin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Anti-D Immunoglobulin Market Size by Type
9.1.1 Asia Anti-D Immunoglobulin Sales by Type (2018-2029)
9.1.2 Asia Anti-D Immunoglobulin Revenue by Type (2018-2029)
9.2 Asia Anti-D Immunoglobulin Market Size by Application
9.2.1 Asia Anti-D Immunoglobulin Sales by Application (2018-2029)
9.2.2 Asia Anti-D Immunoglobulin Revenue by Application (2018-2029)
9.3 Asia Anti-D Immunoglobulin Sales by Region
9.3.1 Asia Anti-D Immunoglobulin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Anti-D Immunoglobulin Revenue by Region (2018-2029)
9.3.3 Asia Anti-D Immunoglobulin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Anti-D Immunoglobulin Market Size by Type
10.1.1 Middle East, Africa and Latin America Anti-D Immunoglobulin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Anti-D Immunoglobulin Market Size by Application
10.2.1 Middle East, Africa and Latin America Anti-D Immunoglobulin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Anti-D Immunoglobulin Sales by Country
10.3.1 Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Anti-D Immunoglobulin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Octapharma
11.1.1 Octapharma Company Information
11.1.2 Octapharma Overview
11.1.3 Octapharma Anti-D Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Octapharma Anti-D Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Octapharma Recent Developments
11.2 Kedrion Biopharma
11.2.1 Kedrion Biopharma Company Information
11.2.2 Kedrion Biopharma Overview
11.2.3 Kedrion Biopharma Anti-D Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Kedrion Biopharma Anti-D Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Kedrion Biopharma Recent Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Overview
11.3.3 Grifols Anti-D Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Grifols Anti-D Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols Recent Developments
11.4 Saol Therapeutics
11.4.1 Saol Therapeutics Company Information
11.4.2 Saol Therapeutics Overview
11.4.3 Saol Therapeutics Anti-D Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Saol Therapeutics Anti-D Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Saol Therapeutics Recent Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Overview
11.5.3 Bayer Anti-D Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Bayer Anti-D Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bayer Recent Developments
11.6 Bio Products Laboratory
11.6.1 Bio Products Laboratory Company Information
11.6.2 Bio Products Laboratory Overview
11.6.3 Bio Products Laboratory Anti-D Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Bio Products Laboratory Anti-D Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bio Products Laboratory Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-D Immunoglobulin Industry Chain Analysis
12.2 Anti-D Immunoglobulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-D Immunoglobulin Production Mode & Process
12.4 Anti-D Immunoglobulin Sales and Marketing
12.4.1 Anti-D Immunoglobulin Sales Channels
12.4.2 Anti-D Immunoglobulin Distributors
12.5 Anti-D Immunoglobulin Customers
13 Market Dynamics
13.1 Anti-D Immunoglobulin Industry Trends
13.2 Anti-D Immunoglobulin Market Drivers
13.3 Anti-D Immunoglobulin Market Challenges
13.4 Anti-D Immunoglobulin Market Restraints
14 Key Findings in The Global Anti-D Immunoglobulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-D Immunoglobulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Vial
Table 3. Major Manufacturers of Prefilled Syringes
Table 4. Global Anti-D Immunoglobulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Anti-D Immunoglobulin Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Anti-D Immunoglobulin Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Anti-D Immunoglobulin Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Anti-D Immunoglobulin Revenue Market Share by Region (2018-2024)
Table 9. Global Anti-D Immunoglobulin Revenue Market Share by Region (2024-2029)
Table 10. Global Anti-D Immunoglobulin Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Anti-D Immunoglobulin Sales by Region (2018-2024) & (K Units)
Table 12. Global Anti-D Immunoglobulin Sales by Region (2024-2029) & (K Units)
Table 13. Global Anti-D Immunoglobulin Sales Market Share by Region (2018-2024)
Table 14. Global Anti-D Immunoglobulin Sales Market Share by Region (2024-2029)
Table 15. Global Anti-D Immunoglobulin Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Anti-D Immunoglobulin Sales Share by Manufacturers (2018-2024)
Table 17. Global Anti-D Immunoglobulin Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Anti-D Immunoglobulin Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Anti-D Immunoglobulin, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Anti-D Immunoglobulin Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Anti-D Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Anti-D Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-D Immunoglobulin as of 2022)
Table 23. Global Key Manufacturers of Anti-D Immunoglobulin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Anti-D Immunoglobulin, Product Offered and Application
Table 25. Global Key Manufacturers of Anti-D Immunoglobulin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Anti-D Immunoglobulin Sales by Type (2018-2024) & (K Units)
Table 28. Global Anti-D Immunoglobulin Sales by Type (2024-2029) & (K Units)
Table 29. Global Anti-D Immunoglobulin Sales Share by Type (2018-2024)
Table 30. Global Anti-D Immunoglobulin Sales Share by Type (2024-2029)
Table 31. Global Anti-D Immunoglobulin Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Anti-D Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Anti-D Immunoglobulin Revenue Share by Type (2018-2024)
Table 34. Global Anti-D Immunoglobulin Revenue Share by Type (2024-2029)
Table 35. Anti-D Immunoglobulin Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Anti-D Immunoglobulin Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Anti-D Immunoglobulin Sales by Application (2018-2024) & (K Units)
Table 38. Global Anti-D Immunoglobulin Sales by Application (2024-2029) & (K Units)
Table 39. Global Anti-D Immunoglobulin Sales Share by Application (2018-2024)
Table 40. Global Anti-D Immunoglobulin Sales Share by Application (2024-2029)
Table 41. Global Anti-D Immunoglobulin Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Anti-D Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Anti-D Immunoglobulin Revenue Share by Application (2018-2024)
Table 44. Global Anti-D Immunoglobulin Revenue Share by Application (2024-2029)
Table 45. Anti-D Immunoglobulin Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Anti-D Immunoglobulin Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Anti-D Immunoglobulin Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Anti-D Immunoglobulin Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Anti-D Immunoglobulin Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Anti-D Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Anti-D Immunoglobulin Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Anti-D Immunoglobulin Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Anti-D Immunoglobulin Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Anti-D Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Anti-D Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Anti-D Immunoglobulin Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Anti-D Immunoglobulin Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Anti-D Immunoglobulin Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Anti-D Immunoglobulin Sales by Country (2024-2029) & (K Units)
Table 60. Europe Anti-D Immunoglobulin Sales by Type (2018-2024) & (K Units)
Table 61. Europe Anti-D Immunoglobulin Sales by Type (2024-2029) & (K Units)
Table 62. Europe Anti-D Immunoglobulin Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Anti-D Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Anti-D Immunoglobulin Sales by Application (2018-2024) & (K Units)
Table 65. Europe Anti-D Immunoglobulin Sales by Application (2024-2029) & (K Units)
Table 66. Europe Anti-D Immunoglobulin Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Anti-D Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Anti-D Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Anti-D Immunoglobulin Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Anti-D Immunoglobulin Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Anti-D Immunoglobulin Sales by Country (2018-2024) & (K Units)
Table 72. Europe Anti-D Immunoglobulin Sales by Country (2024-2029) & (K Units)
Table 73. China Anti-D Immunoglobulin Sales by Type (2018-2024) & (K Units)
Table 74. China Anti-D Immunoglobulin Sales by Type (2024-2029) & (K Units)
Table 75. China Anti-D Immunoglobulin Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Anti-D Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Anti-D Immunoglobulin Sales by Application (2018-2024) & (K Units)
Table 78. China Anti-D Immunoglobulin Sales by Application (2024-2029) & (K Units)
Table 79. China Anti-D Immunoglobulin Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Anti-D Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Anti-D Immunoglobulin Sales by Type (2018-2024) & (K Units)
Table 82. Asia Anti-D Immunoglobulin Sales by Type (2024-2029) & (K Units)
Table 83. Asia Anti-D Immunoglobulin Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Anti-D Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Anti-D Immunoglobulin Sales by Application (2018-2024) & (K Units)
Table 86. Asia Anti-D Immunoglobulin Sales by Application (2024-2029) & (K Units)
Table 87. Asia Anti-D Immunoglobulin Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Anti-D Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Anti-D Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Anti-D Immunoglobulin Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Anti-D Immunoglobulin Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Anti-D Immunoglobulin Sales by Region (2018-2024) & (K Units)
Table 93. Asia Anti-D Immunoglobulin Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Anti-D Immunoglobulin Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Anti-D Immunoglobulin Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Anti-D Immunoglobulin Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Anti-D Immunoglobulin Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Anti-D Immunoglobulin Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Anti-D Immunoglobulin Sales by Country (2024-2029) & (K Units)
Table 107. Octapharma Company Information
Table 108. Octapharma Description and Major Businesses
Table 109. Octapharma Anti-D Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Octapharma Anti-D Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Octapharma Recent Developments
Table 112. Kedrion Biopharma Company Information
Table 113. Kedrion Biopharma Description and Major Businesses
Table 114. Kedrion Biopharma Anti-D Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Kedrion Biopharma Anti-D Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Kedrion Biopharma Recent Developments
Table 117. Grifols Company Information
Table 118. Grifols Description and Major Businesses
Table 119. Grifols Anti-D Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Grifols Anti-D Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Grifols Recent Developments
Table 122. Saol Therapeutics Company Information
Table 123. Saol Therapeutics Description and Major Businesses
Table 124. Saol Therapeutics Anti-D Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Saol Therapeutics Anti-D Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Saol Therapeutics Recent Developments
Table 127. Bayer Company Information
Table 128. Bayer Description and Major Businesses
Table 129. Bayer Anti-D Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Bayer Anti-D Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Bayer Recent Developments
Table 132. Bio Products Laboratory Company Information
Table 133. Bio Products Laboratory Description and Major Businesses
Table 134. Bio Products Laboratory Anti-D Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Bio Products Laboratory Anti-D Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Bio Products Laboratory Recent Developments
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Anti-D Immunoglobulin Distributors List
Table 140. Anti-D Immunoglobulin Customers List
Table 141. Anti-D Immunoglobulin Market Trends
Table 142. Anti-D Immunoglobulin Market Drivers
Table 143. Anti-D Immunoglobulin Market Challenges
Table 144. Anti-D Immunoglobulin Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-D Immunoglobulin Product Picture
Figure 2. Global Anti-D Immunoglobulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Anti-D Immunoglobulin Market Share by Type in 2022 & 2029
Figure 4. Vial Product Picture
Figure 5. Prefilled Syringes Product Picture
Figure 6. Global Anti-D Immunoglobulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Anti-D Immunoglobulin Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Anti-D Immunoglobulin Report Years Considered
Figure 11. Global Anti-D Immunoglobulin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Anti-D Immunoglobulin Revenue 2018-2029 (US$ Million)
Figure 13. Global Anti-D Immunoglobulin Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Anti-D Immunoglobulin Revenue Market Share by Region (2018-2029)
Figure 15. Global Anti-D Immunoglobulin Sales 2018-2029 ((K Units)
Figure 16. Global Anti-D Immunoglobulin Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Anti-D Immunoglobulin Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Anti-D Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Anti-D Immunoglobulin Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Anti-D Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Anti-D Immunoglobulin Sales YoY (2018-2029) & (K Units)
Figure 22. China Anti-D Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Anti-D Immunoglobulin Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Anti-D Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Anti-D Immunoglobulin Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Anti-D Immunoglobulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Anti-D Immunoglobulin in the World: Market Share by Anti-D Immunoglobulin Revenue in 2022
Figure 29. Global Anti-D Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Anti-D Immunoglobulin Sales Market Share by Type (2018-2029)
Figure 31. Global Anti-D Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 32. Global Anti-D Immunoglobulin Sales Market Share by Application (2018-2029)
Figure 33. Global Anti-D Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Anti-D Immunoglobulin Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Anti-D Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Anti-D Immunoglobulin Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Anti-D Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Anti-D Immunoglobulin Revenue Share by Country (2018-2029)
Figure 39. US & Canada Anti-D Immunoglobulin Sales Share by Country (2018-2029)
Figure 40. U.S. Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Anti-D Immunoglobulin Sales Market Share by Type (2018-2029)
Figure 43. Europe Anti-D Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 44. Europe Anti-D Immunoglobulin Sales Market Share by Application (2018-2029)
Figure 45. Europe Anti-D Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 46. Europe Anti-D Immunoglobulin Revenue Share by Country (2018-2029)
Figure 47. Europe Anti-D Immunoglobulin Sales Share by Country (2018-2029)
Figure 48. Germany Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 49. France Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 53. China Anti-D Immunoglobulin Sales Market Share by Type (2018-2029)
Figure 54. China Anti-D Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 55. China Anti-D Immunoglobulin Sales Market Share by Application (2018-2029)
Figure 56. China Anti-D Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 57. Asia Anti-D Immunoglobulin Sales Market Share by Type (2018-2029)
Figure 58. Asia Anti-D Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 59. Asia Anti-D Immunoglobulin Sales Market Share by Application (2018-2029)
Figure 60. Asia Anti-D Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 61. Asia Anti-D Immunoglobulin Revenue Share by Region (2018-2029)
Figure 62. Asia Anti-D Immunoglobulin Sales Share by Region (2018-2029)
Figure 63. Japan Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 67. India Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Anti-D Immunoglobulin Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Anti-D Immunoglobulin Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Anti-D Immunoglobulin Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Anti-D Immunoglobulin Sales Share by Country (2018-2029)
Figure 74. Brazil Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Anti-D Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 79. Anti-D Immunoglobulin Value Chain
Figure 80. Anti-D Immunoglobulin Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries